Hepatocellular carcinoma after sustained response to interferon in non‐cirrhotic hepatitis C: Flaws in the cure, or a clue to the flaws?
- 1 September 1999
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 14 (9) , 833-837
- https://doi.org/10.1046/j.1440-1746.1999.01977.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patientsJournal of Hepatology, 1999
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type CJournal of Hepatology, 1997
- Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: A multivariate analysis in 343 patientsJournal of Gastroenterology and Hepatology, 1997
- Risk factors and prevention of hepatocellular carcinoma in HCV infectionDigestive Diseases and Sciences, 1996
- Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?Hepatology, 1996
- HCV-associated hepatocellular carcinoma without cirrhosisJournal of Hepatology, 1996
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- HCV-associated liver cancer without cirrhosisThe Lancet, 1995
- The role of hepatitis B virus in development of primary hepatocellular carcinoma: Part IIJournal of Gastroenterology and Hepatology, 1993
- The role of hepatitis B virus in the development of primary hepatocellular carcinoma: Part IJournal of Gastroenterology and Hepatology, 1992